Andrew Chase, Catherine Bryant, Joannah Score, Claudia Haferlach, Vera Grossmann, Juliana Schwaab, Wolf-Karsten Hofmann, Andreas Reiter, and Nicholas C.P. Cross. 2013. “Ruxolitinib As Potential Targeted Therapy for Patients With JAK2 Rearrangements”. Haematologica 98 (3). Pavia, Italy, 404-8. https://doi.org/10.3324/haematol.2012.067959.